Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: DRA: Canada Impact+ Research Training Awards - Doctoral

McGill University

$120,000.00

Amyloid Fibril formation by TPPP

EF 2025-26

Résumé
"This PhD project will investigate the molecular mechanisms, structural determinants, and cellular consequences of amyloid fibril formation by the tubulin polymerization-promoting protein (TPPP). TPPP is a microtubule-associated protein enriched ir oligodendrocytes and a major component of glial cytoplasmic inclusions in Multiple System Atrophy (MSA). However, how TPPP transitions from a physiological microtubule regulator to a pathogenic amyloid protein remains unknown. Aim 1: In vitro reconstitution and structural characterization of TPPP fibrils. Olivia will establish biochemical assays to induce and monitor TPPP fibrillization under defined conditions. Fibril formation kinetics will be quantified using ThT fluorescence, sedimentation assays, and mass photometry. Crye-electron microscopy will be used to determine fibril architecture and identify structural elements that drive amyloid assembly. Mutational analysis guided by structural models will test determinants of fibril stability and nucleation. Aim 2: Cellular consequences of TPPP aggregation. Using oligodendrocyte and RPE-1 cell models, Olivia will express fluorescently tagged TPPP variants to assess aggregation dynamics, subcellular localization, and interaction with microtubules. Live-cell imaging and biochemical fractionation will distinguish soluble, microtubule-bound, and aggregated pools. She will test whether amyloid-prone mutations alter microtubule organization or induce proteostatic stress. Aim 3: In vivo relevance and disease modeling. The project will extend to in vivo systems (e.g., transgenic or viral expression models) to assess whether TPPP aggregation disrupts myelination, microtubule organization, or oligodendrocyte function. Together, these studies will define how structural instability of TPPP drives amyloid formation and cellular dysfunction, providing mechanistic insight into MSA pathogenesis."
Programme
DRA: Canada Impact+ Research Training Awards - Doctoral
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
568135
Name
Cartron Olivia M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Canada Impact+ Research Training Awards - Doctoral
Projecttitle
Amyloid Fibril formation by TPPP
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA: Canada Impact+ Research Training Awards - Doctoral
Keyworddelim
Amyloid Fibrils; Cryo-Electron Microscopy; Multiple System Atrophy; Neurodegeneration
Abstract
"This PhD project will investigate the molecular mechanisms, structural determinants, and cellular consequences of amyloid fibril formation by the tubulin polymerization-promoting protein (TPPP). TPPP is a microtubule-associated protein enriched ir oligodendrocytes and a major component of glial cytoplasmic inclusions in Multiple System Atrophy (MSA). However, how TPPP transitions from a physiological microtubule regulator to a pathogenic amyloid protein remains unknown. Aim 1: In vitro reconstitution and structural characterization of TPPP fibrils. Olivia will establish biochemical assays to induce and monitor TPPP fibrillization under defined conditions. Fibril formation kinetics will be quantified using ThT fluorescence, sedimentation assays, and mass photometry. Crye-electron microscopy will be used to determine fibril architecture and identify structural elements that drive amyloid assembly. Mutational analysis guided by structural models will test determinants of fibril stability and nucleation. Aim 2: Cellular consequences of TPPP aggregation. Using oligodendrocyte and RPE-1 cell models, Olivia will express fluorescently tagged TPPP variants to assess aggregation dynamics, subcellular localization, and interaction with microtubules. Live-cell imaging and biochemical fractionation will distinguish soluble, microtubule-bound, and aggregated pools. She will test whether amyloid-prone mutations alter microtubule organization or induce proteostatic stress. Aim 3: In vivo relevance and disease modeling. The project will extend to in vivo systems (e.g., transgenic or viral expression models) to assess whether TPPP aggregation disrupts myelination, microtubule organization, or oligodendrocyte function. Together, these studies will define how structural instability of TPPP drives amyloid formation and cellular dysfunction, providing mechanistic insight into MSA pathogenesis."
Competitiondate
202603
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cartron, Olivia M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~